A longitudinal study defined circulating micrornas as reliable biomarkers for disease prognosis and progression in als human patients

HIGHLIGHTS

• who: Gabriella Dobrowolny from the (UNIVERSITY) have published the research: A longitudinal study defined circulating microRNAs as reliable biomarkers for disease prognosis and progression in ALS human patients, in the Journal: (JOURNAL)
• what: To disclose a possible difference in disease progression of patients enrolled in the study , the authors evaluated the decline in the clinical rate of patients enrolled in the study. By this approach, the authors provided evidence that serum levels of miR-206, miR133a and miR-151a-5p can predict disease course and severity. Until now, in the ALS field, miRNAs biomarkers have . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.